These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8843273)

  • 1. Pancreatic transplantation after thirty years: still room for improvement.
    Bartlett ST
    J Am Coll Surg; 1996 Oct; 183(4):408-10. PubMed ID: 8843273
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO; Bowman JL; Penzak SR
    Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis with oral fluconazole and an oral solution of amphotericin B in liver transplant patients.
    Fortun J; Martin-Davila P; de Vicente E; Nuño J; Alvarez ME; Sanchez-Sousa A; Barcena R; Lopez-San roman A; Candelas A; Honrubia A; Navas E; Moreno S
    Transplant Proc; 2002 Feb; 34(1):80-1. PubMed ID: 11959195
    [No Abstract]   [Full Text] [Related]  

  • 5. Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant.
    Mossad SB; Avery RK; Bolwell BJ
    Clin Infect Dis; 2003 Jun; 36(11):1503-4; author reply 1504. PubMed ID: 12766853
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial.
    Patel R
    Liver Transpl; 2000 May; 6(3):376-9. PubMed ID: 10827245
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia.
    Odds FC
    Clin Infect Dis; 2003 May; 36(10):1229-31. PubMed ID: 12746766
    [No Abstract]   [Full Text] [Related]  

  • 8. Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study.
    Biancofiore G; Bindi ML; Baldassarri R; Romanelli AM; Catalano G; Filipponi F; Vagelli A; Mosca F
    Transpl Int; 2002 Jul; 15(7):341-7. PubMed ID: 12122510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention and treatment of fungal infections in solid-organ transplant recipients].
    Muñoz P; Bouza E
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():38-48. PubMed ID: 9441304
    [No Abstract]   [Full Text] [Related]  

  • 10. Liposomal amphotericin B for fever and neutropenia.
    Wingard JR
    N Engl J Med; 1999 Oct; 341(15):1153; author reply 1154-5. PubMed ID: 10515753
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral amphotericin B inefficacy in the treatment of fluconazole++ resistant oropharyngeal candidiasis in HIV-positive patients].
    Laguna F; Valencia E; Polo R; Moreno V; González-Lahoz JM
    Rev Clin Esp; 1996 Dec; 196(12):878-9. PubMed ID: 9132869
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluconazole-resistant pseudomembranous oral candidiasis.
    Shetty K
    Ann Pharmacother; 2006 May; 40(5):993. PubMed ID: 16638917
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
    Singhal S; Ellis RW; Jones SG; Miller SJ; Fisher NC; Hastings JG; Mutimer DJ
    Liver Transpl; 2000 Sep; 6(5):588-95. PubMed ID: 10980058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida endophthalmitis: focus on current and future antifungal treatment options.
    Khan FA; Slain D; Khakoo RA
    Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
    Kramer KM; Skaar DJ; Ackerman BH
    Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
    Burgaleta C
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():31-7. PubMed ID: 9441303
    [No Abstract]   [Full Text] [Related]  

  • 17. Fungal infections after lung transplantation.
    Solé A; Salavert M
    Transplant Rev (Orlando); 2008 Apr; 22(2):89-104. PubMed ID: 18631862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis.
    Reichenspurner H; Gamberg P; Nitschke M; Valantine H; Hunt S; Oyer PE; Reitz BA
    Transplant Proc; 1997; 29(1-2):627-8. PubMed ID: 9123449
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiology of fungemia in a university hospital; therapeutic incidence].
    Pavese P; Brion JP; Lebeau B; Grillot R; Ambroise-Thomas P
    Pathol Biol (Paris); 1999 May; 47(5):579-83. PubMed ID: 10418046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal infections in neonates: update on prevention and treatment.
    Kaufman DA
    Minerva Ginecol; 2007 Jun; 59(3):311-29. PubMed ID: 17576407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.